Budget Impact Analysis of 13-Valent Pneumococcal Vaccine in Adult Population with Comorbidities or Immunocompromised from the Public Payer Perspective In Brazil.

Ferreira, C N; Manfrin, D F; Rufino, C S; Gea, Y; Haas, L C; Fernandes, R A

Ferreira, C N; Manfrin, D F; Rufino, C S; Gea, Y; Haas, L C; Fernandes, R A.

Affiliation

Ferreira CN; Pfizer, Inc., New York, NY, USA.
Manfrin DF; Pfizer, Inc., São Paulo, Brazil.
Rufino CS; Pfizer, Inc., São Paulo, Brazil.
Gea Y; Pfizer, Inc., São Paulo, Brazil.
Haas LC; ANOVA, Rio de Janeiro, Brazil.
Fernandes RA; ANOVA, Rio de Janeiro, Brazil.

Value Health ; 17(7): A667-8, 2014 Nov.

Article in En | MEDLINE | ID: mdl-27202438

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation Country/Region as subject: America do sul / Brasil Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2014 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google